GlassScriptPhysician profile
Austin S Reeves
NPI 1962408674
$32,682.67
in general payments reported to CMS, 2019-2025
9 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $30.66 · 2021: $149 · 2022: $213 · 2023: $13.67 · 2024: $12K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $31K · Food and Beverage: $13.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $31,142.00 |
| Food and Beverage | $13.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $31,142.00 | 2024-2025 | |
| Pylant Medical | $1,115.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $125.77 | 2021-2022 | |
| Triad Life Sciences INC. | $100.07 | 2022 | |
| Tactile Systems Technology INC | $70.35 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Boston Scientific Corporation | $63.39 | 2021 | |
| Depuy Synthes Sales INC. | $30.28 | 2022 | |
| Melinta Therapeutics, LLC | $19.07 | 2019 | |
| Baudax Bio INC. | $16.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.